BackgroundCheck.run
Search For

Mark E Wall, 5913 Village Ct, Hurffville, NJ 08080

Mark Wall Phones & Addresses

13 Village Ct, Sewell, NJ 08080    856-3749081    856-7289243   

Sicklerville, NJ   

Andalusia, PA   

Philadelphia, PA   

Gloucester, NJ   

Work

Company: Keystone mercy health - Philadelphia, PA Feb 2010 Position: Claims examiner

Education

School / High School: Harris School of Business- Cherry Hill, NJ Oct 2008 Specialities: Diploma

Mentions for Mark E Wall

Mark Wall resumes & CV records

Resumes

Mark Wall Photo 49

Mark Wall

Mark Wall Photo 50

Mark Julio Wall

Mark Wall Photo 51

Mark Wall

Mark Wall Photo 52

Director At Cavanaugh Wall Solutions, Inc.

Position:
Director at Cavanaugh Wall Solutions, Inc. (Sole Proprietorship)
Location:
United States
Industry:
Construction
Work:
Cavanaugh Wall Solutions, Inc.
Director
Mark Wall Photo 53

Mark Wall

Location:
United States
Mark Wall Photo 54

Mark Wall - Willingboro, NJ

Work:
Keystone Mercy Health - Philadelphia, PA Feb 2010 to Oct 2010
Claims Examiner
BMS - Lawrenceville, NJ Oct 2008 to Aug 2009
Teacher's Aide
Advantage Sales & Marketing - Delran, NJ Oct 2007 to Oct 2008
Part -Time Merchandiser
OSI Collections - Levittown, PA Nov 2004 to Aug 2005
Hourly Representative
Education:
Harris School of Business - Cherry Hill, NJ Oct 2008
Diploma
Burlington County College - Mount Laurel, NJ Dec 2007
Associates of Arts in Education
Burlington County Institute of Technology - Westampton, NJ Jun 2003
Diploma in Cisco Networking

Publications & IP owners

Us Patents

Pyrrolopyridazine Compounds And Methods Of Use Thereof For The Treatment Of Proliferative Disorders

US Patent:
7030112, Apr 18, 2006
Filed:
Sep 26, 2003
Appl. No.:
10/672850
Inventors:
Mark E. Salvati - Lawrencevile NJ, US
Carl R. Illig - Phoenixville PA, US
Kenneth Jerome Wilson - West Grove PA, US
Jinsheng Chen - Exton PA, US
Sanath K. Meegalla - Boothwyn PA, US
Mark James Wall - Harleysville PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 487/04
C07D 487/14
A61K 31/5025
A61P 5/28
A61P 35/00
US Classification:
5142332, 544235, 544116, 514248
Abstract:
Disclosed are pyrrolopyridazine compounds of the formula, wherein the substituents are defined herein,methods of preparing such compounds, and their use for the treatment of proliferative, inflammatory, and other disorders.

Thiophene Amidines, Compositions Thereof, And Methods Of Treating Complement-Mediated Diseases And Conditions

US Patent:
7109354, Sep 19, 2006
Filed:
May 28, 2003
Appl. No.:
10/445817
Inventors:
Nalin Subasinghe - West Chester PA, US
Ehab Khalil - West Chester PA, US
Kristi Leonard - West Chester PA, US
Farah Ali - Exton PA, US
Heather Rae Hufnagel - Glenmoore PA, US
Jeremy M. Travins - Newtown Square PA, US
Shelley K. Ballentine - Lansdale PA, US
Kenneth T. Wilson - West Grove PA, US
Maxwell D. Cummings - Wayne PA, US
Wenxi Pan - Glenmoore PA, US
Joan Gushue - Collegeville PA, US
Sanath Meegalla - Boothwyn PA, US
Mark Wall - Harleysville PA, US
Jinsheng Chen - Exton PA, US
M. Jonathan Rudolph - Exton PA, US
Hui Huang - Belle Mead NJ, US
Assignee:
3-Dimensional Pharmaceuticals, Inc. - Yardley PA
International Classification:
C07D 333/02
C07D 333/32
US Classification:
549 29, 549 64, 549 70, 549 83
Abstract:
Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula I.

Thiophene Amidines, Compositions Thereof, And Methods Of Treating Complement-Mediated Diseases And Conditions

US Patent:
7138530, Nov 21, 2006
Filed:
May 28, 2003
Appl. No.:
10/515554
Inventors:
Nalin Subasinghe - West Chester PA, US
Ehab Khalil - West Chester PA, US
Kristi A. Leonard - West Chester PA, US
Farah Ali - Exton PA, US
Heather Hufnagel - Glenmoore PA, US
Jeremy M. Travins - Newtown Square PA, US
Shelley K. Ballentine - Lansdale PA, US
Kenneth T. Wilson - Media PA, US
Maxwell D. Cummings - Wayne PA, US
Wenxi Pan - Glenmoore PA, US
Joan Gushue - Collegeville PA, US
Sanath Meegalla - Boothwyn PA, US
Mark Wall - Harleysville PA, US
Jinsheng Chen - Exton PA, US
Jonathan M. Rudolph - Doylestown PA, US
Hui Huang - Belle Meade NJ, US
Assignee:
3-Dimensional Pharmaceuticals, Inc. - Yardley PA
International Classification:
C07D 333/32
A61K 31/38
US Classification:
549 65, 514445
Abstract:
Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula (I) or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R, R, R, Rand Rare defined in the specification, Z is SO or SO, and Ar is an aromatic or heteroaromatic group as defined herein.

Quinolinone Derivatives As Inhibitors Of C-Fms Kinase

US Patent:
7326788, Feb 5, 2008
Filed:
Jul 20, 2004
Appl. No.:
10/894940
Inventors:
Mark J. Wall - Harleysville PA, US
Mark R. Player - Phoenixville PA, US
Raymond Joseph Patch - Yardley PA, US
Sanath Meegalla - Boothwyn PA, US
Jian Liu - Plainsboro NJ, US
Carl R. Illig - Phoenixville PA, US
Wing Cheung - Plainsboro NJ, US
Jinsheng Chen - Exton PA, US
Davoud Asgari - Newtown PA, US
Assignee:
Janssen Pharmaceutica N.V. - Beerse
International Classification:
C07D 215/38
C07D 215/44
US Classification:
546157, 546153
Abstract:
The invention is directed to compounds of Formulae I and II:.

Inhibitors Of C-Fms Kinase

US Patent:
7414050, Aug 19, 2008
Filed:
Apr 18, 2007
Appl. No.:
11/736617
Inventors:
Carl R. Illig - Phoenixville PA, US
Shelly K. Ballentine - Lansdale PA, US
Jinsheng Chen - Exton PA, US
Renee Louise DesJarlais - Saint Davids PA, US
Sanath K. Meegalla - Boothwyn PA, US
Mark Wall - Flourtown PA, US
Kenneth Wilson - Media PA, US
Assignee:
Janssen Pharmaceutica, N.V. - Beerse
International Classification:
C07D 417/04
C07D 417/14
A61K 31/541
US Classification:
5142225, 544 5, 544 8
Abstract:
The invention is directed to compounds of Formula I:.

Inhibitors Of C-Fms Kinase

US Patent:
7645755, Jan 12, 2010
Filed:
Apr 20, 2006
Appl. No.:
11/408096
Inventors:
Carl R. Illig - Phoenixville PA, US
Shelley K. Ballentine - Lansdale PA, US
Jinsheng Chen - Exton PA, US
Sanath K. Meegalla - Boothwyn PA, US
M. Jonathan Rudolph - Doylestown PA, US
Mark J. Wall - Harleysville PA, US
Kenneth J. Wilson - Media PA, US
Renee L. Desjarlais - Saint Davids PA, US
Carl L. Manthey - Downingtown PA, US
Christopher Flores - Lansdale PA, US
Christopher J. Molloy - Yardley PA, US
Assignee:
Janssen Pharmaceutical N.V. - Beerse
International Classification:
A61K 31/5377
A61K 31/454
C07D 413/14
C07D 401/02
US Classification:
5142358, 514326, 544129, 546210
Abstract:
The invention is directed to compounds of Formula I:.

Inhibitors Of C-Fms Kinase

US Patent:
7662837, Feb 16, 2010
Filed:
Oct 20, 2005
Appl. No.:
11/254276
Inventors:
Carl R. Illig - Phoenixville PA, US
Shelley K. Ballentine - Lansdale PA, US
Jinsheng Chen - Exton PA, US
Sanath K. Meegalla - Boothwyn PA, US
M. Jonathan Rudolph - Doylestown PA, US
Mark J. Wall - Harleysville PA, US
Kenneth J. Wilson - Media PA, US
Renee L. Desjarlais - Saint Davids PA, US
Carl L. Manthey - Downingtown PA, US
Christopher Flores - Lansdale PA, US
Christopher J. Molloy - Yardley PA, US
Assignee:
Janssen Pharmaceutica N.V.
International Classification:
A61K 31/454
C07D 401/02
US Classification:
514326, 546210
Abstract:
The invention is directed to compounds of Formula I:.

Class Of Arylamide Compounds Useful As Inhibitors Of C-Fms Kinase

US Patent:
7705042, Apr 27, 2010
Filed:
Oct 20, 2005
Appl. No.:
11/255043
Inventors:
Carl R. Illig - Phoenixville PA, US
Shelley K. Ballentine - Lansdale PA, US
Jinsheng Chen - Exton PA, US
Sanath Meegalla - Boothwyn PA, US
Jonathan Rudolph - Doylestown PA, US
Mark J. Wall - Harleysville PA, US
Kenneth J. Wilson - West Grove PA, US
Renee DesJarlais - Saint Davids PA, US
Carl L. Manthey - Downingtown PA, US
Christopher M. Flores - Lansdale PA, US
Christopher J. Molloy - Yardley PA, US
Assignee:
Janssen Pharmaceutica NV
International Classification:
A61K 31/34
US Classification:
514461, 544 56, 544 60, 544106, 544359, 546207, 5462681, 5483415, 548564, 549505
Abstract:
The invention relates to arylamide and hetereoarylamide compounds of Formula I:.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.